These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20971510)

  • 21. What is in a name? Refined diagnostic criteria for prognostic assessment in myelodysplastic syndrome (MDS).
    Deeg HJ
    Leuk Res; 2004 Jun; 28(6):543-4. PubMed ID: 15120927
    [No Abstract]   [Full Text] [Related]  

  • 22. Outcome of patients with myelodysplastic syndromes: experience from a single institution in South Australia.
    Hui CH; Horvath N; Lewis I; To LB; Szabo F
    Intern Med J; 2008 Nov; 38(11):824-8. PubMed ID: 18284457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality of life in myelodysplastic syndromes. A special report from the Myelodysplastic Syndromes Foundation, Inc.
    Heptinstall K;
    Oncology (Williston Park); 2008 Feb; 22(2 Suppl Nurse Ed):13-8; discussion 19. PubMed ID: 18434977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of transfusion dependency and secondary iron overload on the survival of patients with myelodysplastic syndromes.
    Malcovati L
    Leuk Res; 2007 Dec; 31 Suppl 3():S2-6. PubMed ID: 18037415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MDS researchers seek treatments but find few.
    Bankhead C
    J Natl Cancer Inst; 2007 Jul; 99(13):996-7. PubMed ID: 17596568
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of pediatric myelodysplastic syndromes and juvenile myelomonocytic leukemia: the Brazilian experience in the past decade.
    Valera ET; Latorre Mdo R; Mendes WL; Seber A; Lee ML; de Paula MJ; Loggetto SR; Velloso E; Niero-Melo L; Lopes LF;
    Leuk Res; 2004 Sep; 28(9):933-9. PubMed ID: 15234570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Myelodysplastic diseases in childhood].
    Niemeyer C; Stollmann-Gibbels B; Ebell W; Gaedicke G; Creutzig U
    Klin Padiatr; 1992; 204(4):190-7. PubMed ID: 1518255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diagnosis and therapy strategy in myelodysplastic syndromes].
    Gattermann N; Aul C
    Praxis (Bern 1994); 1996 Jan; 85(3):39-44. PubMed ID: 8578048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in MDS.
    Schiffer CA
    Clin Adv Hematol Oncol; 2007 Jun; 5(6):450-2. PubMed ID: 17679919
    [No Abstract]   [Full Text] [Related]  

  • 30. [Myelodysplastic syndromes (MDS) in children].
    Chybicka A
    Pol Arch Med Wewn; 1998 Feb; 99(2):137-43. PubMed ID: 9686515
    [No Abstract]   [Full Text] [Related]  

  • 31. [An analysis of prognostic factors in 80 myelodysplastic syndrome].
    Xu XQ; Wang JM; Lu SQ; Chen L; Yang JM; Zhang WP; Song XM; Xu YQ; Gong SL; Hou J; Ni X
    Zhonghua Xue Ye Xue Za Zhi; 2008 Nov; 29(11):723-7. PubMed ID: 19176004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. World Health Organization and international prognostic scoring system: the limitations of current classification systems in assessing prognosis and determining appropriate therapy in myelodysplastic syndromes.
    Schiffer CA
    Semin Hematol; 2008 Jan; 45(1):3-7. PubMed ID: 18179963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based review.
    Oliansky DM; Antin JH; Bennett JM; Deeg HJ; Engelhardt C; Heptinstall KV; de Lima M; Gore SD; Potts RG; Silverman LR; Jones RB; McCarthy PL; Hahn T
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):137-72. PubMed ID: 19167676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Re-evaluation of classification of myelodysplastic syndromes with low percentage bone marrow blasts].
    Yu MH; Xu ZF; Li L; Nie L; Liu L; Zhang Y; Qin TJ; Hao YS; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):3-7. PubMed ID: 19563026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The point on myelodysplastic syndromes.
    Turtureanu-Hanganu E
    Rev Med Chir Soc Med Nat Iasi; 2004; 108(1):9-16. PubMed ID: 15688749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flow cytometric analysis of myelomonocytic cells by a pattern recognition approach is sensitive and specific in diagnosing myelodysplastic syndrome and related marrow diseases: emphasis on a global evaluation and recognition of diagnostic pitfalls.
    Stachurski D; Smith BR; Pozdnyakova O; Andersen M; Xiao Z; Raza A; Woda BA; Wang SA
    Leuk Res; 2008 Feb; 32(2):215-24. PubMed ID: 17675229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [How to improve the results of treatment of myelodysplastic syndromes in the studies of Polish pediatric leukemia/lymphoma group].
    Chybicka A; Kołecki P; Pietras W; Wójcik D; Turkiewicz D; Armata J; Eliasińska A; Kowalczyk J; Jackowska T; Klus K; Matysiak M; Krauze A; Stefańska K; Rokicka-Milewska R; Wiśniewska-Slusarz H
    Wiad Lek; 1998; 51 Suppl 4():45-51. PubMed ID: 10731943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact on survival of different treatments for myelodysplastic syndromes (MDS).
    Nachtkamp K; Kündgen A; Strupp C; Giagounidis A; Kobbe G; Gattermann N; Haas R; Germing U
    Leuk Res; 2009 Aug; 33(8):1024-8. PubMed ID: 19185917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapy-related myelodysplastic syndrome in childhood: a retrospective study of 36 patients in Japan.
    Tsurusawa M; Manabe A; Hayashi Y; Akiyama Y; Kigasawa H; Inada H; Noguchi Y; Sawai N; Kobayashi R; Nagatoshi Y; Kawakami K; Kojima S; Nakahata T;
    Leuk Res; 2005 Jun; 29(6):625-32. PubMed ID: 15863201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.